Glycoforms of CA125 antigen as a possible cancer marker

被引:46
作者
Jankovic, Miroslava M. [1 ]
Milutinovic, Bojana S. [1 ]
机构
[1] Univ Belgrade, Inst Applicat Nucl Energy INEP, Zemun Belgrade 11080, Serbia
关键词
amniotic fluid; CA125; carcinoma cell line; glycoforms; glycosylation; lectin-binding;
D O I
10.3233/CBM-2008-4104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CA125, a coelomic epithelium-related antigen, is expressed in both normal and pathological conditions. In this study, we compared the glycosylation of CA125 antigen from amniotic fluid and the ovarian carcinoma cell line OVCAR-3, in order to detect possible differences as a specific marker of their origin. Antigens from both sources were radiolabelled and subsequently subjected to the affinity chromatography, using plant lectins differing in carbohydrate specificity as ligands. A common chromatographic scheme was applied to all columns, i.e. they were eluted with: a) washing buffer to wash out non-bound and low-affinity bound fractions, b) a solution of inhibitory sugar and c) a low pH buffer, to release the high affinity bound fractions. CA125 antigen from each source was found to be heterogeneous in respect to the existence of multiple glycoforms, with O-linked glycan chains predominating. However, the binding patterns of both N- and O-linked glycan-reactive lectins indicated distinct differences in carbohydrate composition between CA125 antigen isolated from amniotic fluid and OVCAR-3 cell line. The observed specificites of CA125-oligosaccharide chains might be of special importance from the biomedical aspect, in terms of their possible use for clinical evaluation of gynecological functions in health and disease.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 31 条
[1]   The performance of screening tests for ovarian cancer: results of a systematic review [J].
Bell, R ;
Petticrew, M ;
Sheldon, T .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (11) :1136-1147
[2]   A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels [J].
Benboubker, L ;
Valat, C ;
Linassier, C ;
Cartron, G ;
Delain, M ;
Bout, M ;
Fetissof, F ;
Lefranq, T ;
Lamagnere, JP ;
Colombat, P .
ANNALS OF ONCOLOGY, 2000, 11 (11) :1485-1491
[3]  
Brockhausen I., 1997, GLYCOPROTEINS HUMAN, P157
[4]  
CUMMINGS RD, 1994, METHOD ENZYMOL, V230, P66
[5]  
CUMMINGS RD, 1997, GLYCOSCIENCES STATUS, P191
[6]  
DAVIS HM, 1986, CANCER RES, V46, P6143
[7]   Glycoprotein glycosylation and cancer progression [J].
Dennis, JW ;
Granovsky, M ;
Warren, CE .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :21-34
[8]  
Goldstein I.J., 1986, LECTINS PROPERTIES F, P35, DOI DOI 10.1016/B978-0-12-449945-4.50007-5
[9]   PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY [J].
GREENWOOD, FC ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1963, 89 (01) :114-&
[10]  
HAKOMORI SI, 1989, ADV CANCER RES, V52, P257